Business Description
IQVIA Holdings Inc
NAICS : 621399
SIC : 8099
ISIN : US46266C1053
Compare
Compare
Traded in other countries / regions
IQV.USAIQV.MexicoQTS.GermanyI1QV34.BrazilIQVH.Austria0JDM.UK IPO Date
2013-05-09Description
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.22 | |||||
| Debt-to-Equity | 2.44 | |||||
| Debt-to-EBITDA | 4.62 | |||||
| Interest Coverage | 3.48 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.03 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.8 | |||||
| 3-Year EBITDA Growth Rate | 15 | |||||
| 3-Year EPS without NRI Growth Rate | 81.3 | |||||
| 3-Year FCF Growth Rate | 25.8 | |||||
| 3-Year Book Growth Rate | -0.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 11.48 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.7 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 23.88 | |||||
| 9-Day RSI | 25.35 | |||||
| 14-Day RSI | 28.5 | |||||
| 6-1 Month Momentum % | 16.71 | |||||
| 12-1 Month Momentum % | 23.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.81 | |||||
| Quick Ratio | 0.81 | |||||
| Cash Ratio | 0.23 | |||||
| Days Sales Outstanding | 31.95 | |||||
| Days Payable | 96.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.2 | |||||
| Shareholder Yield % | 3.43 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 34.82 | |||||
| Operating Margin % | 12.94 | |||||
| Net Margin % | 7.47 | |||||
| ROE % | 19.47 | |||||
| ROA % | 4.36 | |||||
| ROIC % | 6.67 | |||||
| ROC (Joel Greenblatt) % | 224.28 | |||||
| ROCE % | 9.93 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 33.86 | |||||
| Forward PE Ratio | 16.49 | |||||
| PE Ratio without NRI | 33.86 | |||||
| Shiller PE Ratio | 52.47 | |||||
| Price-to-Owner-Earnings | 25.9 | |||||
| PEG Ratio | 2.2 | |||||
| PS Ratio | 2.56 | |||||
| PB Ratio | 6.27 | |||||
| Price-to-Free-Cash-Flow | 23.23 | |||||
| Price-to-Operating-Cash-Flow | 16.33 | |||||
| EV-to-EBIT | 25.47 | |||||
| EV-to-Forward-EBIT | 14.32 | |||||
| EV-to-EBITDA | 16.1 | |||||
| EV-to-Forward-EBITDA | 12.37 | |||||
| EV-to-Revenue | 3.33 | |||||
| EV-to-Forward-Revenue | 3 | |||||
| EV-to-FCF | 30.8 | |||||
| Price-to-Projected-FCF | 1.56 | |||||
| Price-to-DCF (Earnings Based) | 2.51 | |||||
| Price-to-DCF (FCF Based) | 0.96 | |||||
| Price-to-Median-PS-Value | 1.04 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.26 | |||||
| Earnings Yield (Greenblatt) % | 3.93 | |||||
| Forward Rate of Return (Yacktman) % | 18.59 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:IQV
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IQVIA Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 14,681 | ||
| EPS (TTM) ($) | 5.81 | ||
| Beta | 1.28 | ||
| Volatility % | 33.2 | ||
| 14-Day RSI | 28.5 | ||
| 14-Day ATR ($) | 4.445515 | ||
| 20-Day SMA ($) | 210.9565 | ||
| 12-1 Month Momentum % | 23.97 | ||
| 52-Week Range ($) | 165.75 - 241.86 | ||
| Shares Outstanding (Mil) | 183.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IQVIA Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IQVIA Holdings Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
IQVIA Holdings Inc Frequently Asked Questions
What is IQVIA Holdings Inc(IQV)'s stock price today?
The current price of IQV is $196.75. The 52 week high of IQV is $241.86 and 52 week low is $165.75.
When is next earnings date of IQVIA Holdings Inc(IQV)?
The next earnings date of IQVIA Holdings Inc(IQV) is 2023-10-26 Est..
Does IQVIA Holdings Inc(IQV) pay dividends? If so, how much?
IQVIA Holdings Inc(IQV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers